ZEALAND PHARMA A/S revenue for the last year amounted to 45.97 M EUR, the most of which — 45.97 M EUR — came from its highest performing source at the moment, Peptide-based Medicines, the year earlier bringing 13.94 M EUR. The greatest contribution to the revenue figure was made by Germany — last year it brought ZEALAND PHARMA A/S 39.50 B EUR.